Newton, MA, United States of America

Siamab Therapeutics, Inc.


USPTO Granted Patents = 4


Forward Citations = 42

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Darius Ghaderi (2 out of 2 patents)

silverMedal Ana Paula Galvao Da Silva (2 out of 2 patents)

bronzeMedal Jeffrey Behrens (1 out of 4 patents)

4.  Alexey Alexandrovich Lugovskoy (1 out of 52 patents)

5.  Julie DeSander (1 out of 2 patents)

6.  Ajit Varki (1 out of 11 patents)

7.  Richard B Schwab (1 out of 1 patent)

8.  Vered Padler-Karavani (1 out of 3 patents)

9.  Nancy Hurtado-Ziola (1 out of 1 patent)

10.  Richard Schwab (0 patent)


4 patents:

Company Overview
Siamab Therapeutics, Inc. is a biopharmaceutical company focused on developing novel cancer immunotherapies. They are pioneering the use of antibody-drug conjugates to target and treat a wide range of solid tumors. With a strong pipeline of drug candidates and a team of experienced scientists, Siamab is committed to advancing the field of oncology and improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#69 in Newton, MA

#3,313 in Massachusetts

#60,641 in US

Newton, MA (US)
Newton, MA, United States of America
Forward Citations = 42

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Siamab Therapeutics, Inc.. Retrieved from https://idiyas.com/company/siamab-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…